2009
Established
10,000
Attendees
1,500
Speakers
1,250
Companies
“PMWC has created an outstanding forum that touches every component of precision medicine and convenes all of its stakeholders.
I am honored to be part of this experience and to be able to influence the structure and focus of the upcoming PMWC 2017 SV conference.”
Keith Yamamoto, PhD, PMWC 2017 Silicon Valley Program Chair
How To Engage Community Oncologists in Precision Medicine
Session Co-Chairs: Lincoln Nadauld, Intermountain Health Care; Laurence Marton, PMWC 2014 Program Chair

Immunotherapy: Emerging Applications and Therapies
Session Chair: James Allison, MD Anderson Cancer Center

Human Biospecimen Acquisition; Risks, Challenges and Solutions
Session Chair: Matt McLoughlin, Scientist.com

CIAPM: Accelerating Precision Medicine Advances in California
Session Chair: Elizabeth Baca, Governor’s Office of Planning and Research; Uta Grieshammer, CIAPM

How to Commercialize Disruptive Technologies That Advance Precision Medicine
Session Chair: Alex De Winter, GE Ventures

An Update on the Cancer Moonshot and Brain Government Initiatives
Session Chair: Joshua Gordon, National Institute of Mental Health

Health Systems as Translational Research Partners
Session Chair: Walter “Buzz” Stewart, Sutter Health

Understanding Human Health and Diseases at the Individual Level
Session Chair: Euan Ashley, Stanford Clinical Genomics Service

Bringing Liquid Biopsy to the Clinic: Overcoming Fundamental Challenges
Session Chair: Walter Koch, Roche

Personalized Medicine – The Cinderella Story of Venture Investments?
Session Chair: Mara Aspinall, Genepeeks

How Immuno-oncology Saved My Life: A Patient’s Perspective
Session Chair: Andrew Schorr, Patient Power

Predictive Biomarkers and Companion Diagnostics for Immuno-Oncology
Session Chair: Brad Gray, NanoString Technologies

Generating Insights from Multi-modal Healthcare Data for Precision Medicine
Session Chair: Atul Butte, UCSF

Issues and Challenges of Immunotherapy
Session Chair: Larry Corey, Fred Hutchinson Cancer Research Center

The Last Clinical Mile of Precision Medicine – Challenges at the Point of Care
Session Chair: Assaf Halevy, 2bPrecise

Emerging Technologies Hold Promise to Inform the Practice of Precision Medicine
Session Chair: John Ryals, Metabolon

Immunotherapy: Immunocheckpoint Inhibitors & Beyond
Session Chair: Irv Weissman, Stanford School of Medicine

Precision Medicine Patent Law Update
Session Chairs: Catherine Polizzi, Morrison and Foerster and Michael Shuster, Fenwick & West

How To Engage Community Oncologists in Precision Medicine
Session Co-Chairs: Lincoln Nadauld, Intermountain Health Care; Laurence Marton, PMWC 2014 Program Chair

Immunotherapy: Emerging Applications and Therapies
Session Chair: James Allison, MD Anderson Cancer Center

Human Biospecimen Acquisition; Risks, Challenges and Solutions
Session Chair: Matt McLoughlin, Scientist.com

CIAPM: Accelerating Precision Medicine Advances in California
Session Chair: Elizabeth Baca, Governor’s Office of Planning and Research; Uta Grieshammer, CIAPM

How to Commercialize Disruptive Technologies That Advance Precision Medicine
Session Chair: Alex De Winter, GE Ventures

An Update on the Cancer Moonshot and Brain Government Initiatives
Session Chair: Joshua Gordon, National Institute of Mental Health

Health Systems as Translational Research Partners
Session Chair: Walter “Buzz” Stewart, Sutter Health

Understanding Human Health and Diseases at the Individual Level
Session Chair: Euan Ashley, Stanford Clinical Genomics Service

Bringing Liquid Biopsy to the Clinic: Overcoming Fundamental Challenges
Session Chair: Walter Koch, Roche

Personalized Medicine – The Cinderella Story of Venture Investments?
Session Chair: Mara Aspinall, Genepeeks

How Immuno-oncology Saved My Life: A Patient’s Perspective
Session Chair: Andrew Schorr, Patient Power

Predictive Biomarkers and Companion Diagnostics for Immuno-Oncology
Session Chair: Brad Gray, NanoString Technologies

Generating Insights from Multi-modal Healthcare Data for Precision Medicine
Session Chair: Atul Butte, UCSF

Issues and Challenges of Immunotherapy
Session Chair: Larry Corey, Fred Hutchinson Cancer Research Center

The Last Clinical Mile of Precision Medicine – Challenges at the Point of Care
Session Chair: Assaf Halevy, 2bPrecise

Emerging Technologies Hold Promise to Inform the Practice of Precision Medicine
Session Chair: John Ryals, Metabolon

Immunotherapy: Immunocheckpoint Inhibitors & Beyond
Session Chair: Irv Weissman, Stanford School of Medicine

Precision Medicine Patent Law Update
Session Chairs: Catherine Polizzi, Morrison and Foerster and Michael Shuster, Fenwick & West
Testimonials
“PMWC has proven, time and time again, that it attracts thought-leaders from all the relevant fields and catalyzes crucial collaboration through inspiring and practical program content. This is the Conference for entrepreneurs to meet payors, and for researchers to connect with service providers and for clinicians to hear from leading providers.”
Lee Hood, PhD, MD“PMWC provides a valuable insight for physicians and others who may be wondering how close we are getting to realizing the arrival of personalized medicine. The conferences are helpful in understanding where and how the envelope is being pushed.”
Peter Paul Yu, MD, FACP, FASCO“PMWC is a very well organized conference based in Silicon Valley that addresses all of the salient issues facing personalized medicine and offers emerging personalized medicine companies a chance to showcase their latest innovations, reminding us how exciting the field is.”
Ed Abrahams, PhD